Chronic Kidney Disease
Despite recommendations, statin use ‘not ubiquitous’ in CKD with ASCVD
Overall statin use among adults with chronic kidney disease is high, yet there have been only modest increases in the use of high‐intensity statins, ezetimibe and PCSK9 inhibitors, data from a prospective 2‐year study show.
About half of patients in nephrology know a plant-based diet can improve CKD
A survey of various patients in nephrology revealed that more than half knew a plant-based diet can be beneficial for chronic kidney disease, according to data published in the Journal of Renal Nutrition.
Presenter: Novel methods are needed to implement intradialytic exercise
Intradialytic exercise is difficult to implement, but the right methods may yield significant benefits for patients, according to a presenter at the International Conference on Dialysis.
Wearable devices may have a future in kidney care, but challenges remain
Wearable devices may play a significant role in the future of kidney care, according to a presenter at the International Conference on Dialysis.
Premature aging may play a role in the progression of CKD
A better understanding of chronic kidney disease may be found in the study of aging, according to a presenter at the International Conference on Dialysis.
Race-free eGFR equation attenuates racial disparities in accrual of preemptive wait time
In a theoretical context, the 2021 creatine-based Chronic Kidney Disease Epidemiology Collaboration equation reduced racial differences in preemptive wait time accrual more than the use of the creatinine-cystatin equation, this study shows.
FDA grants approval of Terlivaz injection to treat patients with hepatorenal syndrome
The FDA has announced approval of Terlivaz, a terlipressin injection formulation by Mallinckrodt plc., to treat patients with hepatorenal syndrome with rapid reduction in kidney function.
More than half of patients report decisional conflict about kidney failure modalities
A high prevalence of patients with chronic kidney disease report decisional conflict about kidney failure treatment, regardless of their risk of kidney failure, according to data published in Kidney Medicine.
Conference chair: ‘Time of change’ for innovation, but new products for ESKD stay elusive
Five years of debate on advances in technology for treating kidney disease has not resulted in new products coming to market, but change is underway, the Innovations in Dialysis: Expediting Advances program chair said in recent remarks.
More prescriptions a patient has linked with poor nutritional status in those with CKD
Among patients with chronic kidney disease, the more medication prescriptions one has is associated with poor nutritional status, according to data published in the Journal of Renal Nutrition.